Affordable Access

deepdyve-link
Publisher Website

Generalized estimating equation model to compare drug effects on synovitis of the dominant wrist in severe rheumatoid arthritis between tocilizumab versus adalimumab versus abatacept using high-resolution ultrasound.

Authors
  • Chen, Ying-Chou1
  • Chiu, Wen-Chan1
  • Su, Fu-Mei1
  • Chen, Jia-Feng1
  • 1 Department of Rheumatology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Taiwan. , (Taiwan)
Type
Published Article
Journal
International Journal of Rheumatic Diseases
Publisher
Wiley (Blackwell Publishing)
Publication Date
Oct 12, 2017
Identifiers
DOI: 10.1111/1756-185X.13188
PMID: 29024421
Source
Medline
Keywords
License
Unknown

Abstract

In a 6-month head-to-head comparison of patients with RA, tocilizumab and adalimumab had a greater effect on reducing synovial hypertrophy, while adalimumab had a greater effect in controlling inflammation in PD.

Report this publication

Statistics

Seen <100 times